1. House of Lords Select Committee on Science and Technology Seventh Report. Resistance to Antibiotics and Other Antimicrobial Agents
[online]
, (Stationary Office, London, UK, 1998).
2. Shlaes, D. M. et al. Antibiotic discovery: state of the state. ASM News 70, 275–281 (2004).
3. Talbot, G. H. et al. Bad bugs need drugs: an update on the development pipeline from the antibacterial availability task force of the IDSA. Clin. Infect. Dis. 42, 657–668 (2006).
4. Wenzel, R. P. The antibiotic pipeline — challenges, costs, and values. N. Engl. J. Med. 351, 523–526 (2004).
5. Infectious Disease Society of America. Bad Bugs, No Drugs
[online]
, (2004). Seminal review by key opinion leaders on the shrinking investment by big pharma in antibacterial discovery, and the growing challenge of resistant pathogens.